domperidone has been researched along with Nausea in 93 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this randomized, double-blind, phase 3 study, children ages 6 months to 12 years with acute gastroenteritis randomly (1:1) received oral domperidone 0." | 9.30 | Safety and Efficacy of Low-dose Domperidone for Treating Nausea and Vomiting Due to Acute Gastroenteritis in Children. ( Appiani, C; Garces-Sanchez, M; Gupta, R; Hu, P; Leitz, G; Li, Q; Mitha, E, 2019) |
| "We investigated the usefulness of concurrent therapy of granisetron with methylprednisolone sodium for on nausea, vomiting and anorexia induced by chemotherapy, including cisplatin, in patients with oral cancer." | 9.07 | [Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin]. ( Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T, 1993) |
| " CMF were included in a double-blind comparative study aimed at evaluating the efficacy of 3 different drugs (methylprednisolone (MP), metoclopramide (MTC), and domperidone (DMP) in preventing chemotherapy-induced nausea and vomiting." | 9.06 | Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF. ( Ballatori, E; Basurto, C; del Favero, A; Minotti, V; Roila, F; Tonato, M, 1987) |
| "A randomized double-blind cross-over study was performed to evaluate the possible anti-emetic effect of the partial opiate antagonist buprenorphine in comparison to domperidone in chemotherapy-induced nausea and vomiting." | 9.06 | Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study. ( Dullemond-Westland, AC; Neijt, JP; Nortier, JW; Sitsen, JM, 1986) |
| "In a single-blind trial of therapy in 20 patients with idiopathic Parkinson disease, domperidone prevented nausea and vomiting induced by bromocriptine without diminishing beneficial central effects." | 9.05 | Bromocriptine and domperidone in the treatment of Parkinson disease. ( Agid, Y; Illas, A; Lhermitte, F; Quinn, N, 1981) |
| "Domperidone improves symptoms of gastroparesis, reducing overall gastroparesis symptom severity and decreasing early satiety, postprandial fullness, and nausea." | 7.88 | Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary. ( Heckert, J; Parkman, HP, 2018) |
| "There is increased awareness about risks and benefits of using domperidone to treat gastroparesis." | 7.83 | Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort. ( Midani, D; Parkman, HP; Parupalli, R; Roberts, AC; Saadi, M; Schey, R, 2016) |
| "This retrospective audit demonstrates that domperidone is safe in the treatment of nausea associated with inpatient DHE infusion and headache." | 7.83 | Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache. ( Goadsby, PJ; Ito, H; Robbins, NM; Scheinman, MM, 2016) |
| "A retrospective chart review was conducted of patients with nausea (N) and vomiting (V) receiving domperidone from 2009 to 2013 under an Investigational New Drug (IND) protocol." | 7.81 | Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting. ( Alvarez, A; Cooper, CJ; Gomez, Y; McCallum, RW; Ortiz, A; Sarosiek, I, 2015) |
| "To retrospectively analyze the individual risk factors for radioactive iodine (RAI)-associated nausea and vomiting, and to examine the anti-emetic effect of ramosetron (5-hydroxytryptamine-3 receptor antagonist) in RAI therapy." | 7.80 | Moderate to severe nausea in radioactive iodine (RAI) therapy is associated with the RAI dose per body weight and was not prevented by ramosetron. ( Ando, T; Ikeoka, T; Imaizumi, M; Kawakami, A; Ueki, I; Usa, T, 2014) |
| "Our aim was to determine whether domperidone could improve the symptoms of patients with gastroparesis, accelerate gastric emptying, and enhance quality of life." | 7.69 | The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. ( McCallum, RW; Sarosiek, I; Soykan, I, 1997) |
| "Comparative study was performed for assessing the postoperative anti-emetic and emesis preventive effect of domperidone." | 7.68 | The importance of domperidone (Motilium) in controlling postoperative nausea and vomiting. ( Lencz, L, 1990) |
| "Sulpiride, which has been utilized as an antipeptic ulcer and antidepressant in Japan, is one of the dopamine antagonists, and is considered to have anti vomiting activity." | 7.67 | [Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method]. ( Kawakami, K; Kawatsu, S; Komatsu, Y; Okamoto, K; Sakata, Y; Satoh, T; Suzuki, H; Takagi, S; Tanabe, K; Yoshida, Y, 1986) |
| "At the end of the treatment period, nausea, vomiting and reflux symptoms, adverse events and a global assessment of patients' symptom control were recorded by the investigator." | 6.67 | A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting. ( Miller, AJ; Patel, NH; Roy, P, 1991) |
| "Droperidol was significantly more effective than domperidone, metoclopramide or placebo in reducing emetic sequelae." | 6.66 | Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. ( Madej, TH; Simpson, KH, 1986) |
| " High-dose metoclopramide has demonstrated efficacy in small series of patients in the treatment of cisplatin-induced vomiting." | 6.15 | Advances in anti-emetic therapy. ( Bakowski, MT, 1984) |
| "In this randomized, double-blind, phase 3 study, children ages 6 months to 12 years with acute gastroenteritis randomly (1:1) received oral domperidone 0." | 5.30 | Safety and Efficacy of Low-dose Domperidone for Treating Nausea and Vomiting Due to Acute Gastroenteritis in Children. ( Appiani, C; Garces-Sanchez, M; Gupta, R; Hu, P; Leitz, G; Li, Q; Mitha, E, 2019) |
| " The aim of this study was to compare the effectiveness and tolerability of a fixed combination of domperidone and paracetamol (Domperamol; Servier), which has anti-nauseant and anti-emetic activity, with sumatriptan 50 mg in moderate to severe migraine." | 5.09 | Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study. ( Ball, K; Dowson, A; Haworth, D, 2000) |
| " During 5 days prior to the apomorphine all received Motilium (domperidone, 60 mg/d) to prevent nausea and vomiting." | 5.09 | [Apomorphine for treatment of "off-periods" in Parkinson's disease]. ( Kuritzky, A; Melamed, E; Merims, D; Ziv, I; Zoldan, J, 1999) |
| "Both drugs are effective, but domperidone (3 x 20 mg) is more effective than ondansetron (3 x 8 mg) for the prevention of the delayed nausea and/or vomiting which occur after highly emetogenic chemotherapy (p < 0." | 5.08 | Prophylaxis of delayed nausea and vomiting after cancer chemotherapy. ( Borm, JJ; Esseboom, EU; Rojer, RA; Statius van Eps, LW, 1995) |
| "We investigated the usefulness of concurrent therapy of granisetron with methylprednisolone sodium for on nausea, vomiting and anorexia induced by chemotherapy, including cisplatin, in patients with oral cancer." | 5.07 | [Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin]. ( Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T, 1993) |
| "A randomized double-blind cross-over study was performed to evaluate the possible anti-emetic effect of the partial opiate antagonist buprenorphine in comparison to domperidone in chemotherapy-induced nausea and vomiting." | 5.06 | Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study. ( Dullemond-Westland, AC; Neijt, JP; Nortier, JW; Sitsen, JM, 1986) |
| " CMF were included in a double-blind comparative study aimed at evaluating the efficacy of 3 different drugs (methylprednisolone (MP), metoclopramide (MTC), and domperidone (DMP) in preventing chemotherapy-induced nausea and vomiting." | 5.06 | Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF. ( Ballatori, E; Basurto, C; del Favero, A; Minotti, V; Roila, F; Tonato, M, 1987) |
| "Domperidone was evaluated as an antiemetic in the control of nausea and vomiting associated with the administration of cytotoxic chemotherapy for various malignancies in a paediatric population." | 5.05 | Domperidone as an antiemetic in paediatric oncology. ( Mott, MG; O'Meara, A, 1981) |
| "In a single-blind trial of therapy in 20 patients with idiopathic Parkinson disease, domperidone prevented nausea and vomiting induced by bromocriptine without diminishing beneficial central effects." | 5.05 | Bromocriptine and domperidone in the treatment of Parkinson disease. ( Agid, Y; Illas, A; Lhermitte, F; Quinn, N, 1981) |
| "To evaluate the risk of QT prolongation, ventricular arrhythmias and sudden cardiac death associated with the use of oral domperidone in adults without cancer." | 4.91 | [Cardiac adverse effects of domperidone in adult patients: a systematic review]. ( Avila, A; Caraballo, L; Marzi, M; Molina, G; Piskulic, L; Weitz, D, 2015) |
| "A search of two bibliographic databases, the European Medicines Agency (EMA) website, Micromedex, Lexicomp and reference texts was undertaken for domperidone related reports of QT prolongation, cardiac arrhythmias and/or SCD." | 4.91 | Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. ( Buffery, PJ; Strother, RM, 2015) |
| "In patients with advanced cancer not being treated with chemotherapy or radiation therapy, metoclopramide can be used to reduce nausea and vomiting." | 4.88 | [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review]. ( Alt-Epping, B; Benze, G; Geyer, A; Nauck, F, 2012) |
| "Risk-minimization measures (RMM), including label revisions were implemented in Europe for domperidone because of evidence of increased incidence of cardiac arrhythmia and sudden cardiac death." | 3.91 | Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. ( Fife, D; Hu, P; Kaplan, S; Oliveria, SA; Phillips, S; Richarz, U; Waller, J, 2019) |
| "Domperidone is a dopamine antagonist used for the symptomatic management of nausea and vomiting." | 3.91 | Impact of Safety Warning on Domperidone Prescribing for Geriatric Patients in South Korea: Analysis of National Insurance Claim Data. ( Han, N; Oh, JM; Rhew, K, 2019) |
| "Domperidone improves symptoms of gastroparesis, reducing overall gastroparesis symptom severity and decreasing early satiety, postprandial fullness, and nausea." | 3.88 | Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary. ( Heckert, J; Parkman, HP, 2018) |
| "Domperidone, a peripheral D2 dopamine receptor antagonist, has efficacy for treatment of nausea, dyspepsia, and gastroparesis." | 3.85 | Domperidone is Commonly Prescribed With QT-Interacting Drugs: Review of a Community-based Practice and a Postmarketing Adverse Drug Event Reporting Database. ( Alexoff, A; Ehrenpreis, ED; Roginsky, G; Smith, DG, 2017) |
| "There is increased awareness about risks and benefits of using domperidone to treat gastroparesis." | 3.83 | Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort. ( Midani, D; Parkman, HP; Parupalli, R; Roberts, AC; Saadi, M; Schey, R, 2016) |
| "This retrospective audit demonstrates that domperidone is safe in the treatment of nausea associated with inpatient DHE infusion and headache." | 3.83 | Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache. ( Goadsby, PJ; Ito, H; Robbins, NM; Scheinman, MM, 2016) |
| "A retrospective chart review was conducted of patients with nausea (N) and vomiting (V) receiving domperidone from 2009 to 2013 under an Investigational New Drug (IND) protocol." | 3.81 | Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting. ( Alvarez, A; Cooper, CJ; Gomez, Y; McCallum, RW; Ortiz, A; Sarosiek, I, 2015) |
| "To retrospectively analyze the individual risk factors for radioactive iodine (RAI)-associated nausea and vomiting, and to examine the anti-emetic effect of ramosetron (5-hydroxytryptamine-3 receptor antagonist) in RAI therapy." | 3.80 | Moderate to severe nausea in radioactive iodine (RAI) therapy is associated with the RAI dose per body weight and was not prevented by ramosetron. ( Ando, T; Ikeoka, T; Imaizumi, M; Kawakami, A; Ueki, I; Usa, T, 2014) |
| "Domperidone is a dopamine antagonist that has recently been released in Canada." | 3.76 | Domperidone, a new dopamine antagonist. ( Champion, MC; Hartnett, M; Yen, M, 1986) |
| "Our aim was to determine whether domperidone could improve the symptoms of patients with gastroparesis, accelerate gastric emptying, and enhance quality of life." | 3.69 | The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. ( McCallum, RW; Sarosiek, I; Soykan, I, 1997) |
| "Antiemetic effect and safety of concurrent administration of ondansetron and other antiemetics (dexamethasone, domperidone and ethyl loflazepate), given for complete suppression of nausea/vomiting, were examined in 46 patients (109 courses) with gynecological cancer receiving single high-dose of cisplatin or carboplatin." | 3.69 | [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer]. ( Fujii, T; Kioka, H; Naito, H; Nakata, N; Sawasaki, T; Shigemasa, K; Shiroyama, Y; Tanimoto, H, 1997) |
| "Comparative study was performed for assessing the postoperative anti-emetic and emesis preventive effect of domperidone." | 3.68 | The importance of domperidone (Motilium) in controlling postoperative nausea and vomiting. ( Lencz, L, 1990) |
| "The incidence of dyspepsias and emesis occurring either as accompanying symptoms of gynaecological operations or as independent clinical conditions, therapeutic means for controlling these conditions and the mechanism of action and clinical usefulness of the dopamine antagonist domperidone have been discussed." | 3.67 | Use of peripheral dopamine antagonist (Motilium) in the treatment of dyspeptic complaints of different origin and in nausea, vomiting. ( Sásdi, A, 1989) |
| "A dose-finding multicenter study was undertaken to evaluate the antiemetic efficacy of domperidone, an antidopaminergic drug, which has been proposed as a suitable alternative to high-dose metoclopramide in the control of cisplatin-induced nausea and vomiting." | 3.67 | A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin. ( del Favero, A; Franzosi, MG; Pampallona, S; Roila, F; Tognoni, G; Tonato, M, 1985) |
| "Sulpiride, which has been utilized as an antipeptic ulcer and antidepressant in Japan, is one of the dopamine antagonists, and is considered to have anti vomiting activity." | 3.67 | [Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method]. ( Kawakami, K; Kawatsu, S; Komatsu, Y; Okamoto, K; Sakata, Y; Satoh, T; Suzuki, H; Takagi, S; Tanabe, K; Yoshida, Y, 1986) |
| "The administration of alfentanil by continuous infusion as supplementation to nitrous oxide for shortlasting anesthesias has been studied in 51 patients." | 3.66 | Continuous infusion of alfentanil. ( Booij, LH; Pelgrom, R; Steegers, PA, 1982) |
| "The antiemetic effect of domperidone against nausea, vomiting, and anorexia induced by antineoplastic agents was compared with that of chlorpromazine." | 3.66 | [Prophylactic antiemetic treatment for cancer chemotherapy--comparison of domperidone and chlorpromazine]. ( Araki, Y; Seita, M; Tamura, K, 1983) |
| "A recently developed oral serotonergic challenge test consisting of 5-Hydroxytryptophane (5-HTP, 200 mg) combined with carbidopa (CBD, 100 mg + 50 mg) exhibited dose-related neuroendocrine responsiveness and predictable pharmacokinetics." | 2.75 | Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron. ( de Kam, ML; Derijk, RH; Jacobs, GE; Kamerling, IM; van Gerven, JM; van Pelt, J; Zitman, FG, 2010) |
| "At the end of the treatment period, nausea, vomiting and reflux symptoms, adverse events and a global assessment of patients' symptom control were recorded by the investigator." | 2.67 | A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting. ( Miller, AJ; Patel, NH; Roy, P, 1991) |
| "Droperidol was significantly more effective than domperidone, metoclopramide or placebo in reducing emetic sequelae." | 2.66 | Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. ( Madej, TH; Simpson, KH, 1986) |
| "Nausea and vomiting are reported in approximately 60% of neoplastic patients treated with doxorubicin used alone at doses greater than or equal to 50 mg/m2 or in combination with other noncisplatin antiblastic agents." | 2.66 | A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agents. ( Ballatori, E; Basurto, C; Bracarda, S; Del Favero, A; Roila, F; Tonato, M, 1988) |
| " It thus provides an excellent safety profile for long-term administration orally in the recommended doses." | 2.44 | Domperidone: review of pharmacology and clinical applications in gastroenterology. ( McCallum, RW; Reddymasu, SC; Soykan, I, 2007) |
| "Functional vomiting is rare and presents with more frequent vomiting episodes." | 2.44 | Functional nausea and vomiting. ( Talley, NJ, 2007) |
| "Nausea and vomiting are common symptoms of migraine, which can be controlled with a variety of anti-emetics including phenothiazines and antihistamines." | 2.41 | Anti-emetics. ( MacGregor, EA, 2001) |
| "Apomorphine is a potent short-acting D1/D2 dopamine agonist administered sub-cutaneously that is used in the treatment of PD." | 1.35 | The pragmatic use of apomorphine at the end of life. ( Dewhurst, F; Lee, M; Wood, B, 2009) |
| " If nicotinamide was given in combination with domperidone, 86% of the patients continued the nicotinamide medication until the end of the treatment period." | 1.31 | Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy. ( Bussink, J; Folkes, LK; Kaanders, JH; Stratford, MR; van der Kogel, AJ, 2002) |
| "Patients with migraine show a hypersensitivity to dopamine or its agonists." | 1.27 | Pharmacological exploration of dopamine hypersensitivity in migraine patients. ( Bès, A; Bessoles, G; Dupui, P; Géraud, G; Güell, A, 1986) |
| "Domperidone was given twice a day for one week." | 1.27 | [Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy]. ( Hirose, Y; Matsushita, T; Mise, K; Nakanishi, M; Shirosaki, H; Tanaka, T; Yamaoto, T, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (50.54) | 18.7374 |
| 1990's | 12 (12.90) | 18.2507 |
| 2000's | 10 (10.75) | 29.6817 |
| 2010's | 22 (23.66) | 24.3611 |
| 2020's | 2 (2.15) | 2.80 |
| Authors | Studies |
|---|---|
| Monković, I | 1 |
| Willner, D | 1 |
| Adam, MA | 1 |
| Brown, M | 1 |
| Crenshaw, RR | 1 |
| Fuller, CE | 1 |
| Juby, PF | 1 |
| Luke, GM | 1 |
| Matiskella, JA | 1 |
| Montzka, TA | 1 |
| Rhew, K | 1 |
| Han, N | 1 |
| Oh, JM | 1 |
| Kamath, A | 1 |
| Rai, KM | 1 |
| Shreyas, R | 1 |
| Saxena, PUP | 1 |
| Banerjee, S | 1 |
| Yan, XJ | 1 |
| Xu, P | 1 |
| Qiu, HY | 1 |
| Wang, B | 1 |
| Luo, QQ | 1 |
| Chen, SL | 1 |
| Braillon, A | 1 |
| Robbins, NM | 2 |
| Goadsby, PJ | 2 |
| Heckert, J | 1 |
| Parkman, HP | 2 |
| Giusti, R | 1 |
| Mazzotta, M | 1 |
| Filetti, M | 1 |
| Daniele, G | 1 |
| Tsukuura, H | 2 |
| Ficorella, C | 1 |
| Porzio, G | 1 |
| Marchetti, P | 1 |
| Verna, L | 1 |
| Leitz, G | 1 |
| Hu, P | 2 |
| Appiani, C | 1 |
| Li, Q | 1 |
| Mitha, E | 1 |
| Garces-Sanchez, M | 1 |
| Gupta, R | 1 |
| Di Lorenzo, C | 1 |
| Nurko, S | 1 |
| Fife, D | 1 |
| Waller, J | 1 |
| Kaplan, S | 1 |
| Phillips, S | 1 |
| Oliveria, SA | 1 |
| Richarz, U | 1 |
| Ikeoka, T | 1 |
| Ando, T | 1 |
| Imaizumi, M | 1 |
| Ueki, I | 1 |
| Usa, T | 1 |
| Kawakami, A | 1 |
| Ramos, L | 1 |
| Alarcón, O | 1 |
| Adrian, Z | 1 |
| Gimeno-García, AZ | 1 |
| Nicolás-Pérez, D | 1 |
| Jiménez-Sosa, A | 1 |
| Quintero, E | 1 |
| Furyk, JS | 1 |
| Meek, R | 1 |
| McKenzie, S | 1 |
| Shailendra, B | 1 |
| Shailendra, M | 1 |
| Manish, J | 1 |
| Singh, TY | 1 |
| Priti, T | 1 |
| Ortiz, A | 1 |
| Cooper, CJ | 1 |
| Alvarez, A | 1 |
| Gomez, Y | 1 |
| Sarosiek, I | 2 |
| McCallum, RW | 3 |
| Marzi, M | 1 |
| Weitz, D | 1 |
| Avila, A | 1 |
| Molina, G | 1 |
| Caraballo, L | 1 |
| Piskulic, L | 1 |
| Buffery, PJ | 1 |
| Strother, RM | 1 |
| Ando, Y | 1 |
| Gyawali, B | 1 |
| Matsumoto, M | 1 |
| Sugishita, M | 1 |
| Honda, K | 1 |
| Urakawa, H | 1 |
| Maeda, O | 1 |
| Hasegawa, Y | 1 |
| Smith, LA | 1 |
| Azariah, F | 1 |
| Lavender, VT | 1 |
| Stoner, NS | 1 |
| Bettiol, S | 1 |
| Ehrenpreis, ED | 1 |
| Roginsky, G | 1 |
| Alexoff, A | 1 |
| Smith, DG | 1 |
| Schey, R | 1 |
| Saadi, M | 1 |
| Midani, D | 1 |
| Roberts, AC | 1 |
| Parupalli, R | 1 |
| Ito, H | 1 |
| Scheinman, MM | 1 |
| Jacobs, GE | 1 |
| Kamerling, IM | 1 |
| de Kam, ML | 1 |
| Derijk, RH | 1 |
| van Pelt, J | 1 |
| Zitman, FG | 1 |
| van Gerven, JM | 1 |
| Dewhurst, F | 1 |
| Lee, M | 1 |
| Wood, B | 1 |
| Festin, M | 1 |
| Benze, G | 1 |
| Alt-Epping, B | 1 |
| Geyer, A | 1 |
| Nauck, F | 1 |
| Bussink, J | 1 |
| Stratford, MR | 1 |
| van der Kogel, AJ | 1 |
| Folkes, LK | 1 |
| Kaanders, JH | 1 |
| MacGregor, EA | 1 |
| Reddymasu, SC | 1 |
| Soykan, I | 2 |
| Talley, NJ | 1 |
| Robinson, P | 1 |
| Bakowski, MT | 1 |
| Guldager, H | 1 |
| Jensen, FM | 1 |
| Andersen, KH | 1 |
| Arnfred, I | 1 |
| Clarke, RS | 1 |
| Spelina, KR | 1 |
| Gerber, HR | 1 |
| Pagels, IL | 1 |
| Valenzuela, JE | 1 |
| Dooley, CP | 1 |
| Roussak, JB | 1 |
| Carey, P | 1 |
| Parry, H | 1 |
| Usui, N | 1 |
| Ogawa, K | 1 |
| Inagaki, J | 1 |
| Horikoshi, N | 1 |
| Inoue, T | 1 |
| Murakami, M | 2 |
| Urabe, A | 1 |
| Saito, T | 1 |
| Takaku, F | 1 |
| Araki, Y | 1 |
| Tamura, K | 1 |
| Seita, M | 1 |
| Steegers, PA | 1 |
| Booij, LH | 1 |
| Pelgrom, R | 1 |
| Caruso, U | 1 |
| D'Iddio, S | 1 |
| Cravotto, E | 1 |
| Pesce, S | 1 |
| Betti, I | 1 |
| Ruscitto, G | 1 |
| Ecari, U | 1 |
| Sabrie, AM | 1 |
| O'Meara, A | 1 |
| Mott, MG | 1 |
| Minobe, T | 1 |
| Sekine, H | 1 |
| Torii, T | 1 |
| Fujiya, T | 1 |
| Ohtomo, Y | 1 |
| Bogaert, M | 1 |
| Quinn, N | 1 |
| Illas, A | 1 |
| Lhermitte, F | 1 |
| Agid, Y | 1 |
| Esseboom, EU | 1 |
| Rojer, RA | 1 |
| Borm, JJ | 1 |
| Statius van Eps, LW | 1 |
| Kawashima, T | 1 |
| Wada, T | 1 |
| Morita, N | 1 |
| Ohmata, T | 1 |
| Miyata, K | 1 |
| Sakamoto, T | 1 |
| Rampello, L | 1 |
| Raffaele, R | 1 |
| Nicoletti, G | 1 |
| Le Pira, F | 1 |
| Vecchio, I | 1 |
| Malaguarnera, M | 1 |
| Drago, F | 1 |
| Fujii, T | 1 |
| Nakata, N | 1 |
| Shiroyama, Y | 1 |
| Sawasaki, T | 1 |
| Tanimoto, H | 1 |
| Shigemasa, K | 1 |
| Kioka, H | 1 |
| Naito, H | 1 |
| Zoldan, J | 1 |
| Merims, D | 1 |
| Kuritzky, A | 1 |
| Ziv, I | 1 |
| Melamed, E | 1 |
| Dowson, A | 1 |
| Ball, K | 1 |
| Haworth, D | 1 |
| Franchi, F | 1 |
| Lazzeri, C | 1 |
| Barletta, G | 1 |
| Ianni, L | 1 |
| Mannelli, M | 1 |
| Polubiec, A | 1 |
| Krasnopolska-Polanczky, Z | 1 |
| Duda-Król, W | 1 |
| Jórasz, I | 1 |
| Witkowski, J | 1 |
| Varga, A | 1 |
| Lovas, J | 1 |
| Roy, P | 1 |
| Patel, NH | 1 |
| Miller, AJ | 1 |
| Bonuccelli, U | 1 |
| Nocchiero, A | 1 |
| Napolitano, A | 1 |
| Paoletti, AM | 1 |
| Melis, GB | 1 |
| Corsini, GU | 1 |
| Muratorio, A | 1 |
| Lencz, L | 1 |
| Williams, CJ | 1 |
| Davies, C | 1 |
| Raval, M | 1 |
| Middleton, J | 1 |
| Luken, J | 1 |
| Stone, B | 1 |
| Sásdi, A | 1 |
| Cherian, S | 1 |
| Sachdev, HP | 1 |
| Puri, RK | 1 |
| Dodds, LJ | 1 |
| Madej, TH | 2 |
| Simpson, KH | 2 |
| Ota, K | 1 |
| Dalzell, AM | 1 |
| Bartlett, H | 1 |
| Lilleyman, JS | 1 |
| Champion, MC | 2 |
| Cunningham, D | 1 |
| Evans, C | 1 |
| Gazet, JC | 1 |
| Ford, H | 1 |
| Pople, A | 1 |
| Dearling, J | 1 |
| Chappell, D | 1 |
| Coombes, C | 1 |
| Basurto, C | 2 |
| Roila, F | 3 |
| Bracarda, S | 1 |
| Tonato, M | 3 |
| Ballatori, E | 2 |
| Del Favero, A | 3 |
| Fister, T | 1 |
| Wilson, S | 1 |
| Takács, G | 1 |
| Udvardi, G | 1 |
| Minotti, V | 1 |
| Kis Csitári, I | 1 |
| Dullemond-Westland, AC | 1 |
| Neijt, JP | 1 |
| Nortier, JW | 1 |
| Sitsen, JM | 1 |
| Hartnett, M | 1 |
| Yen, M | 1 |
| Nappi, C | 1 |
| Colace, G | 1 |
| Di Renzo, GF | 1 |
| Taglialatela, M | 1 |
| Amoroso, S | 1 |
| Annunziato, L | 1 |
| Montemagno, U | 1 |
| Sakata, Y | 1 |
| Suzuki, H | 1 |
| Satoh, T | 1 |
| Kawatsu, S | 1 |
| Tanabe, K | 1 |
| Okamoto, K | 1 |
| Takagi, S | 1 |
| Komatsu, Y | 1 |
| Kawakami, K | 1 |
| Yoshida, Y | 1 |
| Bès, A | 1 |
| Dupui, P | 1 |
| Güell, A | 1 |
| Bessoles, G | 1 |
| Géraud, G | 1 |
| Waldmann, CS | 1 |
| Verghese, C | 1 |
| Short, SM | 1 |
| Goldhill, DR | 1 |
| Evans, SJ | 1 |
| Huys, J | 1 |
| Troch, M | 1 |
| Bourguignon, RP | 1 |
| Smets, P | 1 |
| Shinkai, T | 1 |
| Saijo, N | 1 |
| Sawamura, N | 1 |
| Funaki, U | 1 |
| Takahashi, S | 1 |
| Yokoyama, S | 1 |
| Fujita, J | 1 |
| Futami, H | 1 |
| Sasaki, Y | 1 |
| Shimizu, E | 1 |
| Cameron, HA | 1 |
| Reyntjens, AJ | 1 |
| Lake-Bakaar, G | 1 |
| Leeser, J | 1 |
| Bateman, DN | 1 |
| Tanaka, T | 1 |
| Nakanishi, M | 1 |
| Hirose, Y | 1 |
| Mise, K | 1 |
| Matsushita, T | 1 |
| Yamaoto, T | 1 |
| Shirosaki, H | 1 |
| Tognoni, G | 1 |
| Franzosi, MG | 1 |
| Pampallona, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Prospective Study to Evaluate the Safety and Efficacy of Domperidone in 6-month-old to 12-year-old Pediatric Subjects With Nausea and Vomiting Due to Acute Gastroenteritis[NCT02699385] | Phase 3 | 10 participants (Actual) | Interventional | 2015-12-07 | Terminated (stopped due to Study prematurely terminated upon recommendation of IDMC due to lack of efficacy.) | ||
| An Investigational New Drug Program for the Use of Domperidone in the Treatment of Refractory Gastroesophageal Reflux Disease and Other Gastrointestinal Motility Disorders[NCT00777439] | 75 participants (Anticipated) | Interventional | 2008-10-31 | Recruiting | |||
| Oral Domperidone for Relief of Gastrointestinal Disorders in Patients Who Failed Standard Therapy[NCT00761254] | 42 participants (Actual) | Interventional | 2008-08-31 | Terminated (stopped due to PI withdrew due to increased responsibilities in clinical department.) | |||
| Does Domperidone, a D2-antagonist Alter Gastric Emptying Rates and Appetite Sensations in Healthy Adults?[NCT01347814] | 13 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for domperidone and Nausea
| Article | Year |
|---|---|
[Cardiac adverse effects of domperidone in adult patients: a systematic review].
Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastroesophag | 2015 |
Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudde | 2015 |
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cannabinoids; Chlorpromazine; Dizziness; Domperidone; Eup | 2015 |
Nausea and vomiting in early pregnancy.
Topics: Acupressure; Administration, Oral; Domperidone; Female; Humans; Metoclopramide; Nausea; Phytotherapy | 2009 |
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].
Topics: Antiemetics; Antipsychotic Agents; Chronic Disease; Domperidone; Dopamine Antagonists; Drug Therapy, | 2012 |
Anti-emetics.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Humans; Metoclopramide; Migraine Disorders; Nausea; | 2001 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Nausea; Vomiting | 2007 |
Functional nausea and vomiting.
Topics: Acute Disease; Antidepressive Agents, Tricyclic; Antiemetics; Chronic Disease; Diagnosis, Differenti | 2007 |
Advances in anti-emetic therapy.
Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Do | 1984 |
Nausea and vomiting.
Topics: Analgesics; Anesthetics; Domperidone; Humans; Metoclopramide; Nausea; Phenothiazines; Piperazines; S | 1984 |
Dopamine antagonists in the upper gastrointestinal tract.
Topics: Diabetic Neuropathies; Digestive System; Domperidone; Dopamine Antagonists; Duodenum; Dyspepsia; Eso | 1984 |
Domperidone-induced acute dystonia and polycystic ovary syndrome.
Topics: Adolescent; Adult; Domperidone; Dyskinesia, Drug-Induced; Dystonia; Estrogens; Female; Humans; Nause | 1991 |
Domperidone.
Topics: Child; Child, Preschool; Domperidone; Gastric Emptying; Humans; Nausea; Vomiting | 1989 |
The control of cancer chemotherapy-induced nausea and vomiting.
Topics: Adrenal Cortex Hormones; Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Antipsychotic Agen | 1985 |
[Recent advances in the management of chemotherapy-induced emesis].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Domperidone; Dronabinol; Drug Therapy, | 1986 |
Domperidone.
Topics: Colonic Diseases, Functional; Domperidone; Dyspepsia; Esophagitis, Peptic; Gastrointestinal Motility | 1988 |
Domperidone, a new dopamine antagonist.
Topics: Administration, Oral; Adult; Child; Clinical Trials as Topic; Domperidone; Dopamine Antagonists; Dys | 1986 |
[The control of chemotherapy-induced nausea and vomiting].
Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Chlorpromazine; Cisplatin; Domperidone; Hum | 1985 |
31 trials available for domperidone and Nausea
| Article | Year |
|---|---|
Antiemetics improve the tolerance of polyethylene glycol for colonoscopy preparation: A randomized clinical trial.
Topics: Adult; Aged; Antiemetics; Cathartics; Colon; Colonoscopy; Domperidone; Female; Humans; Incidence; In | 2021 |
Safety and Efficacy of Low-dose Domperidone for Treating Nausea and Vomiting Due to Acute Gastroenteritis in Children.
Topics: Acute Disease; Administration, Oral; Antiemetics; Child; Child, Preschool; Domperidone; Double-Blind | 2019 |
One-day versus two-day cleansing for colon capsule endoscopy: a prospective randomized pilot study.
Topics: Abdominal Pain; Adult; Aged; Bisacodyl; Capsule Endoscopy; Cathartics; Colon; Dietary Fiber; Domperi | 2014 |
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Antidepressive Agents, Second-Generation; Antiemetics; Area | 2010 |
Advances in anti-emetic therapy.
Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Do | 1984 |
[Domperidone and metoclopramide in the prevention of postoperative nausea and vomiting].
Topics: Abortion, Induced; Adolescent; Adult; Clinical Trials as Topic; Domperidone; Double-Blind Method; Fe | 1983 |
Nausea and vomiting during spinal anaesthesia. Effect of metoclopramide and domperidone: a double-blind trial.
Topics: Aged; Anesthesia, Spinal; Blood Pressure; Clinical Trials as Topic; Domperidone; Double-Blind Method | 1984 |
[Domperidone as an anti-emetic in antineoplastic chemotherapy].
Topics: Aged; Antineoplastic Agents; Benzimidazoles; Clinical Trials as Topic; Domperidone; Female; Gastroin | 1981 |
Domperidone as an antiemetic in paediatric oncology.
Topics: Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Domperidone; | 1981 |
[The effect of domperidone in the prevention of nausea and vomiting during post-operative recovery period from anesthesia--a double blind study (author's transl)].
Topics: Adult; Anesthesia; Clinical Trials as Topic; Domperidone; Double-Blind Method; Female; Humans; Male; | 1981 |
Bromocriptine and domperidone in the treatment of Parkinson disease.
Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Par | 1981 |
Prophylaxis of delayed nausea and vomiting after cancer chemotherapy.
Topics: Adult; Aged; Chi-Square Distribution; Cisplatin; Domperidone; Double-Blind Method; Female; Humans; M | 1995 |
[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
Topics: Adult; Aged; Anorexia; Cisplatin; Domperidone; Drug Therapy, Combination; Female; Granisetron; Human | 1993 |
Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin.
Topics: Adult; Anorexia; Antiemetics; Cimetidine; Domperidone; Female; Histamine H2 Antagonists; Humans; Mal | 1997 |
[Apomorphine for treatment of "off-periods" in Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Domperidone; Female; Humans; Injections, Subcutaneous; Levo | 1999 |
Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Cost-Benefit Analysis; Cross-Over Studies; Domperido | 2000 |
Centrally mediated effects of bromocriptine on cardiac sympathovagal balance.
Topics: Adult; Aortic Bodies; Bromocriptine; Dizziness; Domperidone; Dopamine Agonists; Dopamine Antagonists | 2001 |
Evaluation of the antiemetic effect of domperidon in patients treated with cytostatic drugs.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Domperidone; Female; Humans | 1992 |
A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting.
Topics: Delayed-Action Preparations; Domperidone; Double-Blind Method; Female; Humans; Male; Metoclopramide; | 1991 |
Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.
Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials a | 1989 |
Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery.
Topics: Abdomen; Adult; Antiemetics; Clinical Trials as Topic; Domperidone; Droperidol; Female; Humans; Hyst | 1986 |
Nabilone: an alternative antiemetic for cancer chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; D | 1986 |
Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens.
Topics: Adult; Aged; Ambulatory Care; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dexameth | 1987 |
A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agents.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Domperidone; Double-Blind Method; Doxor | 1988 |
Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1987 |
Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynaecological surgery in day cases.
Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Antiemetics; Clinical Trials as Topic; Dila | 1986 |
Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Buprenorphine; Clinical Trials as Topic; Domperidon | 1986 |
Domperidone, a new dopamine antagonist.
Topics: Administration, Oral; Adult; Child; Clinical Trials as Topic; Domperidone; Dopamine Antagonists; Dys | 1986 |
Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women.
Topics: Adult; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Na | 1987 |
The evaluation of domperidone and metoclopramide as antiemetics in day care abortion patients.
Topics: Abortion, Therapeutic; Adolescent; Adult; Anesthesia, General; Anesthesia, Obstetrical; Clinical Tri | 1985 |
High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
Topics: Antiemetics; Cisplatin; Clinical Trials as Topic; Domperidone; Double-Blind Method; Female; Humans; | 1985 |
46 other studies available for domperidone and Nausea
| Article | Year |
|---|---|
Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis.
Topics: Animals; Antiemetics; Benzamides; Catalepsy; Chemical Phenomena; Chemistry; Cisplatin; Dogs; Dopamin | 1988 |
Impact of Safety Warning on Domperidone Prescribing for Geriatric Patients in South Korea: Analysis of National Insurance Claim Data.
Topics: Aged; Antiemetics; Domperidone; Electrocardiography; Female; Heart Diseases; Humans; Male; Nausea; P | 2019 |
Effect of domperidone, ondansetron, olanzapine-containing antiemetic regimen on QT
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Domperidone; Drug Co | 2021 |
Letter re: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea | 2017 |
Author response: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea | 2017 |
Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Topics: Adult; Antiemetics; Diabetes Complications; Domperidone; Female; Gastric Emptying; Gastroparesis; Hu | 2018 |
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
Topics: Adrenal Cortex Hormones; Adult; Analgesics, Opioid; Antiemetics; Antipsychotic Agents; Cross-Section | 2019 |
It Is Ok to Be Negative!
Topics: Child; Domperidone; Gastroenteritis; Humans; Nausea; Vomiting | 2019 |
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe.
Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Cross-Sectional Studies | 2019 |
Moderate to severe nausea in radioactive iodine (RAI) therapy is associated with the RAI dose per body weight and was not prevented by ramosetron.
Topics: Adenoma; Adult; Aged; Antiemetics; Benzimidazoles; Domperidone; Dose-Response Relationship, Radiatio | 2014 |
Drug treatment of adults with nausea and vomiting in primary care.
Topics: Adult; Antiemetics; Domperidone; Droperidol; Female; Histamine Antagonists; Humans; Male; Metoclopra | 2014 |
Design and Optimization of Domperidone Fast Dissolving Tablet Using Central Composite Design.
Topics: Animals; Antiemetics; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Citric Acid; Domperi | 2015 |
Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting.
Topics: Adult; Cardiotoxicity; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Mon | 2015 |
Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
Topics: Analgesics, Opioid; Antiemetics; Benzodiazepines; Chemoprevention; Domperidone; Health Care Surveys; | 2015 |
Domperidone is Commonly Prescribed With QT-Interacting Drugs: Review of a Community-based Practice and a Postmarketing Adverse Drug Event Reporting Database.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antiemetics; Domperidone; D | 2017 |
Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort.
Topics: Adult; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Diarrhea; Domperidone; Dopamine An | 2016 |
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Adolescent; Adult; Aged; Antiemetics; Dihydroergotamine; Domperidone; Female; Headache; Humans; Male | 2016 |
Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
Topics: Antiemetics; Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Humans; Long QT Synd | 2008 |
The pragmatic use of apomorphine at the end of life.
Topics: Aged; Antiemetics; Antiparkinson Agents; Apomorphine; Blinking; Deglutition Disorders; Domperidone; | 2009 |
Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma; Domperidone; Dose Fractionation, Radiatio | 2002 |
Dosage and drug interactions of domperidone.
Topics: Antiemetics; Domperidone; Dopamine Antagonists; Drug Interactions; Drug Labeling; Gastrointestinal D | 2008 |
Cardiac arrest after treatment with intravenous domperidone.
Topics: Adult; Domperidone; Female; Heart Arrest; Humans; Middle Aged; Nausea; Vomiting | 1984 |
[Domperidone suppositories treatment for nausea and vomiting during cancer chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Domperidone; Female; Humans; Male; Middle Aged; Naus | 1984 |
[Gastrointestinal disturbance by cancer chemotherapy--recent progress in antiemetic regimens].
Topics: Adult; Aged; Animals; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Domper | 1984 |
[Effects of domperidone suppository against adverse reactions in digestive organs induced by cancer chemotherapy].
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Domperidone; Female; Hodgkin Disease; Humans; Leukemia | 1984 |
[Prophylactic antiemetic treatment for cancer chemotherapy--comparison of domperidone and chlorpromazine].
Topics: Adult; Aged; Antineoplastic Agents; Chlorpromazine; Domperidone; Female; Humans; Male; Middle Aged; | 1983 |
Continuous infusion of alfentanil.
Topics: Adult; Alfentanil; Anesthesia; Blood Pressure; Domperidone; Droperidol; Female; Fentanyl; Heart Rate | 1982 |
[Nausea and vomiting: pharmacologic aspects].
Topics: Animals; Antiemetics; Dogs; Domperidone; Humans; Nausea; Receptors, Dopamine; Vomiting | 1982 |
The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Antiemetics; Domperidone; Dopamine Antagonists; E | 1997 |
[Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
Topics: Administration, Oral; Adult; Aged; Anti-Anxiety Agents; Antiemetics; Antineoplastic Combined Chemoth | 1997 |
Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
Topics: Adult; Antiemetics; Domperidone; Drug Administration Schedule; Female; Humans; Incidence; Indoles; M | 1999 |
Some possible gynaecological indications for peripheral antidopamine therapy.
Topics: Adult; Climacteric; Domperidone; Drug Evaluation; Dyspepsia; Female; Gastrointestinal Diseases; Huma | 1992 |
The importance of domperidone (Motilium) in controlling postoperative nausea and vomiting.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Dimenhydrinate; Domperidone; Femal | 1990 |
Use of peripheral dopamine antagonist (Motilium) in the treatment of dyspeptic complaints of different origin and in nausea, vomiting.
Topics: Adolescent; Adult; Aged; Domperidone; Dyspepsia; Female; Genital Diseases, Female; Humans; Hyperemes | 1989 |
Use of Motilium in the perioperative period from the aspect of the anaesthesiologist.
Topics: Adolescent; Adult; Domperidone; Female; Humans; Middle Aged; Nausea; Preanesthetic Medication; Vomit | 1988 |
Domperidone: an alternative to metoclopramide.
Topics: Acute Disease; Adolescent; Adult; Child; Domperidone; Humans; Metoclopramide; Nausea; Vomiting | 1988 |
Domperidone.
Topics: Domperidone; Humans; Nausea; Vomiting | 1988 |
Effect of domperidone on postoperative vomiting and dyspepsia aggravated by operation.
Topics: Adult; Domperidone; Dyspepsia; Female; Humans; Middle Aged; Nausea; Postoperative Complications; Pre | 1988 |
Dopamine antagonist domperidone (Motilium) in everyday clinical practice.
Topics: Adult; Aged; Domperidone; Dyspepsia; Female; Humans; Male; Middle Aged; Nausea; Vomiting | 1988 |
Use of peripheral dopamine receptor antagonist in gynaecology in certain borderline cases.
Topics: Climacteric; Domperidone; Dyspepsia; Female; Gastrointestinal Diseases; Humans; Migraine Disorders; | 1987 |
[Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Domperidone; Drug Evaluation; Female; H | 1986 |
Pharmacological exploration of dopamine hypersensitivity in migraine patients.
Topics: Cerebrovascular Circulation; Domperidone; Dopamine; Headache; Humans; Hypotension; Migraine Disorder | 1986 |
Cardiac arrest after treatment with intravenous domperidone.
Topics: Antineoplastic Agents; Domperidone; Heart Arrest; Humans; Nausea | 1985 |
Domperidone.
Topics: Domperidone; Humans; Nausea; Parkinson Disease | 1985 |
[Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy].
Topics: Adult; Aged; Breast Neoplasms; Cisplatin; Domperidone; Drug Therapy, Combination; Esophageal Neoplas | 1985 |
A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin.
Topics: Adolescent; Adult; Aged; Cisplatin; Domperidone; Female; Humans; Infusions, Parenteral; Male; Middle | 1985 |